Verve Therapeutics Inc (VERV) Stock Price, Quote & News

Latest News on VERV

Mar 24, 2025, 7:00 AM EDT - 10 days ago

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

Mar 3, 2025, 4:05 PM EST - 4 weeks ago

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Feb 27, 2025, 7:00 AM EST - 5 weeks ago

Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 31, 2025, 11:11 AM EST - 2 months ago

Kuehn Law Encourages Investors of Verve Therapeutics, Inc. to Contact Law Firm

Jan 29, 2025, 7:00 AM EST - 2 months ago

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 26, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Shareholders to Learn More About the Investigation

Jan 22, 2025, 10:00 AM EST - 2 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jan 19, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Shareholders to Inquire about Securities Investigation

Jan 15, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Shareholders to Connect

Jan 12, 2025, 10:00 AM EST - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Stockholders to Inquire about Securities Investigation

Jan 8, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Investors to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 3 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 2, 2025, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Investors to Connect

Dec 29, 2024, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Verve Therapeutics, Inc. (VERV) And Encourages Stockholders to Connect

Dec 26, 2024, 10:00 AM EST - 3 months ago

Verve Therapeutics, Inc. (VERV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Dec 22, 2024, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Verve Therapeutics, Inc. (VERV) and Encourages Stockholders to Learn More About the Investigation

Dec 18, 2024, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation

Dec 15, 2024, 10:00 AM EST - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out

Oct 27, 2024, 11:00 AM EDT - 5 months ago

DEADLINE APPROACHING: Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 25, 2024, 11:00 AM EDT - 5 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 22, 2024, 6:05 PM EDT - 5 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics

Oct 19, 2024, 11:00 AM EDT - 5 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Reach Out To The Schall Law Firm

Oct 17, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 15, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Stockholders Are Urged To Help The Schall Law Firm

Oct 13, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 11, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Oct 9, 2024, 11:00 AM EDT - 6 months ago

Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Reach Out To The Schall Law Firm

Oct 4, 2024, 8:40 PM EDT - 6 months ago

VERV REMINDER – Robbins LLP Urges VERV Investors to Obtain Legal Counsel in Light of the Pending Lead Plaintiff Deadline

Oct 1, 2024, 11:00 AM EDT - 6 months ago

Market Cap	347.19M
Revenue (ttm)	32.33M
Net Income (ttm)	-198.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-614.63%
Debt to Equity Ratio	0.00

Volume	2,477,100
Avg Vol	1,430,056
Day's Range	N/A - N/A
Shares Out	88.80M
Stochastic %K	7%
Beta	1.86
Analysts	Strong Sell
Price Target	$22.25